Search

everythinglearnresearchcommunity

for

Search:↓

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

Dermocosmetics help manage skin issues in cancer patients, improving outcomes and reducing treatment interruptions.

Puerto Rican children with cancer often experience symptoms like irritability, nausea, and hair loss, and need better education and continuous symptom management.

The document concludes that scalp cooling and treatments like minoxidil can help manage hair loss from cancer therapy.

Adverse events in lung cancer treatments increase fear, anxiety, and depression, with newer therapies causing fewer side effects.

Men with melanoma have a higher risk of later being diagnosed with prostate cancer.

Endocrine therapies for cancer significantly increase the risk of hair loss.

Age, race, family history, and certain genetic factors increase prostate cancer risk.

Mohs micrographic surgery is effective for early-stage non-melanoma skin cancers on the lips, with basal cell carcinoma more common on the upper cutaneous lip and squamous cell carcinoma more common on the lower vermilion lip.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Topical minoxidil improves hair loss in 80% of women with breast cancer undergoing endocrine therapy.

Anxiety and depression were present but didn't affect overall quality of life in breast cancer patients on chemotherapy.

Ayurveda-based care may improve quality of life for breast cancer patients without serious side effects.

Some side effects of breast cancer chemotherapy last longer than others, and patient feedback can help improve care.

Google should ban ads targeting cancer patients with sensitive health-related keywords to protect them from misleading information.

African plants may help treat cancer by boosting immunity and protecting cells.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

HPV genes and estradiol increase a cancer-related signaling pathway, which may be targeted for cervical cancer treatment.

Scalp hypothermia can prevent chemotherapy-induced hair loss but is not suitable for all patients, and more research is needed to improve prevention methods.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

The Italian version of a relationship scale was adapted for cancer patients, showing some differences from the original and suggesting its use could improve therapy and treatment adherence.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

Scalp cooling helps prevent hair loss during chemotherapy for breast cancer.

Ayurvedic herbs may reduce side effects and improve effectiveness of cancer treatments.

Nutraceuticals that promote hair growth do not reduce tamoxifen's effectiveness in breast cancer treatment.

Reproductive hormones play a crucial role in breast cancer development and treatment challenges.

Hair and scalp pain is more common and severe in breast cancer patients on chemotherapy than those on tamoxifen.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.